Trial Profile
Persistence of Anti-Hep B Antibodies at 12 to 18 Months of Age in Children Having Received Hep B Vaccine at Birth and a DTaP-IPV-HB-Hib Hexavalent Vaccine (Hexaxim or Infanrix Hexa) Concomitantly With Prevnar at 2, 4 and 6 Months of Age
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Hib-DTaP-hepatitis B-poliovirus vaccine (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 24 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 25 Nov 2015 New trial record